SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?


To: jim black who wrote (27493)1/15/2003 10:47:27 PM
From: Raymond Duray  Respond to of 74559
 
LOL! Thanks Jim,

Hey, howza 'bout that RRI! Best thing goin' in da patch dez days. Take a look see. Anyone who lost money on PGO can sure enough make it all back in RRI! I guarandamntee it!



To: jim black who wrote (27493)1/15/2003 10:54:17 PM
From: LLCF  Respond to of 74559
 
Thanks!

DAK



To: jim black who wrote (27493)1/16/2003 1:15:58 AM
From: energyplay  Respond to of 74559
 
Hi Jim - assume you mean "metabolite (DHT) that 1) INCREASES prostate hypertrophy and 2) INCREASES hair loss."

I'll look up the side effect profile, but I wonder about the aromatization of testostorone to estrogen. DHT doesn't convert. Since a lot of the men with prostate problems tend to be obese anyway, with lots of peripheral conversion, this could easily lead to gynomastica.
Of course, tits are better than cancer...



To: jim black who wrote (27493)1/16/2003 10:50:22 AM
From: jim black  Read Replies (1) | Respond to of 74559
 
Indeed I do plead guilty to accepting your correction of my late night wording as an unpleasant reminder of my faltering mind late nights these days. I should have reread and checked the wording. The drug indeed inhibits the growth of prostate tissue by inhibiting an enzyme and probably, since it acts in a similar manner with the other isoenzyme that converts testosterone to DHT, prevents hair loss. They CANNOT say that or even nod silently in agreement without risking the heavy hand of the FDA ( but he grinned silently). Ah, and an additional confession is due, remembered from last night, so intense the energy to refrain from mentioning....that...that religion that I paid not enough attention to the wording of the mesage itself. To your "gotcha," say I "yep, ya did". The comments regarding the potential of a multiyear blockbuster drug stand unchanged. I should also add that to my query of what else was in the pipeline the rep told me that this summer they have coming out a competitor to Viagra that has no cardiac effects and works with a latency of 5 minutes instead of Viagra's 30 minutes. I have not researched the GSK website but it sounds like a lucrative product(duh, now that is a ludicrously low understatement. Some of my patients will be in frenzy or in dogs I would say...heat. By those patients I mean those who have nothing wrong with them in "that direction"= human nature). As far as side effects of Avodart, included are impotence, inability to ejaculate, percentages less than 5% with most people with the side effects saying they disappeared with prolonged use of the drug ~3 months or more. As with any drug that inhibits conversion of testosterone to DHT there is a contraindication in people with prostate cancer.
I keep looking at historical pe's of drug companies about 16-22 and at ~18 GSK does not look that expensive. I will never forget how stupid I felt later after a buddy of mine told me a year in advance of the approach of the release of Viagra. Hindsight! It works 20/15 everytime...damnit
Jim



To: jim black who wrote (27493)1/16/2003 11:57:13 AM
From: Maurice Winn  Read Replies (1) | Respond to of 74559
 
Hi Jim. Re Avodart, I had a brief look at its hair loss prevention, impotence causing, and prostate and PSA shrinkage as well as a few other effects. fda.gov

fda.gov

Also, I had a quick look at Glaxo Smith Kline.

A few comments:

Avodart is small in relation to GSK's overall business and market capitalisation, so it's not going to block bust their profits skywards. Once upon a time [1987] I got really excited about Philips Electronics which had invented CD-ROMs which I thought would take over the world. CD-ROMs did replace tapes and records and gained huge markets in other data delivery applications [such as software]. But Philips was simply too big to gain a major effect, especially when they were gushing the money out the back door as fast as it came in the front. My guess is that Avodart is similar, though not as popular as CD-ROMs.

The market for Avodart is for some older males who are not long for this world anyway and who don't mind the drawbacks of this stuff.

I doubt it'll bring hair back on bald men [the claim is to prevent hair loss].

Mqurice